| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenue | ||||||
20,492 | - | - | ||||
Operating expenses: | ||||||
Research and development | ||||||
54,217 | 36,310 | 19,944 | ||||
General and administrative | ||||||
20,817 | 14,382 | 5,085 | ||||
Total operating expenses | ||||||
75,034 | 50,692 | 25,029 | ||||
Loss from operations | ||||||
-54,542 | -50,692 | -25,029 | ||||
Interest income, net | ||||||
- | - | 44 | ||||
Other expense, net | ||||||
- | - | -10 | ||||
Other income (expense), net | ||||||
3,542 | 1,366 | 34 | ||||
Net loss | ||||||
-51,000 | -49,326 | -24,995 | ||||
Net loss per share, basic and diluted (in dollars per share) | ||||||
-1.85 | -3.15 | -15.30 | ||||
Weighted average common shares outstanding, basic and diluted (in shares) | ||||||
27,537 | 15,655 | 1,634 | ||||
Comprehensive loss: | ||||||
Net loss | ||||||
-51,000 | -49,326 | -24,995 | ||||
Other comprehensive income | ||||||
Unrealized gain on marketable securities | ||||||
45 | -6 | 18 | ||||
Total other comprehensive income | ||||||
45 | -6 | 18 | ||||
Comprehensive loss | ||||||
-50,955 | -49,332 | -24,977 | ||||